Reduce Your Type 2 Diabetes Risk
What is Prediabetes?
Almost 6 million Canadians have prediabetes, and many of them don’t know that they have it. Prediabetes refers to blood sugar levels that are higher than normal, but not high enough to be diagnosed as type 2 diabetes. If left unmanaged, prediabetes can develop into type 2 diabetes – but there are multiple ways to prevent this and change your future. Know your risks - see your pharmacist for a personalized risk assessment.Manage your Diabetes - Your Pharmacist Can Help
If you’ve been diagnosed with diabetes, our pharmacy team can help. In collaboration with your primary care provider, our pharmacists can help manage your medications and reduce your risk of diabetes-related complications such as high blood pressure, weight management, heart disease, and much more.Select pharmacy locations have Pharmacists who are certified diabetes educator (CDE) designated. They can support you throughout your lifelong journey with diabetes. Book an appointment here with our CDE pharmacist for advice and other resources:
- Blood glucose monitoring tips
- Treatment options
- A diabetes action plan and goal setting
- Lifestyle and nutrition tips
To learn more, pick up your complimentary copy “Living Well with Diabetes” instore.
Continuous Glucose Monitoring Devices
Continuous glucose monitors (CGM) are valuable tools to assist people with diabetes manage their disease. These devices give present and past glucose levels and predict where glucose levels are likely to go without having to prick your fingers.There are two types of CGMs: intermittently scanned (isCGM) and real time (rtCGM). Both types use a sensor worn on the body and a hand-held device (a reader or a smartphone with an app) to read glucose levels. isCGM require the user to place a reader or smartphone close to the sensor to capture glucose data, while rtCGM uses blue tooth technology to continuously send data to the reader or smartphone without user action.
All CGM devices can be programmed to alert users to glucose levels that are too high or too low, making it possible to avoid severe high or low blood sugars. CGM technology offers users other benefits. The time that glucose levels remain in a specified target range is tracked by the CGM reader. This makes it possible to make informed decisions about treatment. If you are considering CGM, it is important to talk to your pharmacist to see if it is right for you.
Manage your diabetes with confidence. Ask for Dexcom G7 CGM System
Simple. Accurate.†,1 Effective.- The most accurate CGM System available to Canadians †,1, clinically proven to lower A1C for people living with Type 1 and Type 2 diabetes.2-7
The most accurate CGM system1,† just got better
- Relentless innovation, that's the Dexcom difference.
No routine finger pricks* or scanning
- Make routine fingersticks a thing of the past.* Real-time monitoring of your glucose levels, day and night.
Glucose readings in real time
- Make smarter decisions with confidence about insulin, food, and activity in the moment, to take better control of your diabetes.
Glucose readings in real time
- Make smarter decisions with confidence about insulin, food, and activity in the moment, to take better control of your diabetes.
Alerts before you’re low
- Dexcom G7 can predict when you’re going low so you can take action to prevent it.
All-in-one wearable
- The smallest CGM1 that’s easy-to-use and painless to apply.1,8
To learn more, speak with our pharmacist or visit: Dexcom.
Disclaimer:
† When compared with CGM systems commercially available in Canada as of October 2023.
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1 Dexcom, data on file, 2023.
2 Beck, RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7 Heinemann L, et al. Lancet 2018;391 :1367-77.
8 Patients reported 94% of insertions were painless (mild, no pain).
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1 Dexcom, data on file, 2023.
2 Beck, RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7 Heinemann L, et al. Lancet 2018;391 :1367-77.
8 Patients reported 94% of insertions were painless (mild, no pain).